Kontigo Care AB (KONT) Fair Value & Analysis
Healthcare · SE · Market cap 52.9M SEK (≈ $5.5M) · ISIN SE0007075247
What is Kontigo Care AB really worth?
Below-average quality, trading 20% below our fair value of kr 1.56.
Risks
Fair value as of: Aug 19, 2026
From 2 valuation models · updated 12 days ago
Share price −18.3% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
- The price sits below our cautious bear case: the market assumes less than even our pessimistic scenario.
- Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range kr 1.25 – kr 6.24 · fair‑value band kr 1.27 – kr 1.87 · the kr 1.25 price screens below the kr 1.56 fair value. Dashed = 300-day average. As of Aug 19, 2026.
Analysis
Kontigo Care AB (KONT) currently trades at kr 1.25, while our model-based Fair Value estimate is kr 1.56, implying the stock looks roughly 20.1% undervalued today. The Quality Score stands at 19/100 (below-average quality), in the Healthcare sector. How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the evidence level at low.
Over the trailing twelve months, Kontigo Care AB generated revenue of 35.2M SEK at a net margin of −3.7%. Revenue declined 14.5% year over year. It earns a return on equity of −2.5%. The balance sheet holds a net cash position of 14.9M SEK. Fundamentals as of Aug 19, 2026
Our scenario range runs from kr 1.27 (bear case) to kr 1.87 (bull case); at kr 1.25, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 49% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −68% fair-value upside, at 25%, KONT screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 2 models by family
Widest divergence: Multiples (kr 1.84) versus Asset-Based (kr 0.9600). Highest evidence: EV/EBITDA (67).
Notify me when KONT reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 29 · Market factors (momentum, volatility) 22
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Care, a digital support for addiction care and mental illness; and Previct Safety for real-time digital drug testing. The company was incorporated in 2013 and is based in Uppsala, Sweden.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Kontigo Care AB reported revenue of 29.1M SEK in FY2025 versus 24.5M SEK in FY2021, a compound +4.4%/yr. Reported net income was −2.1M SEK in FY2025.
Watch KONT: get an alert when its fair value changes →
Peer Group
Health Information Services · 131 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $282.13 | $91.49 | −68% |
| Pro Medicus Limited PME | A$183.71 | A$23.74 | −87% |
| BrightSpring Health Services, Inc BTSG | $59.68 | $21.31 | −64% |
| HealthEquity, Inc HQY | $104.27 | $56.63 | −46% |
| Hinge Health, Inc HNGE | $86.32 | $24.03 | −72% |
| 10x Genomics, Inc TXG | $55.63 | $17.18 | −69% |
| Waystar Holding WAY | $24.54 | $12.86 | −48% |
| XtalPi Holdings 2228 | HK$8.19 | HK$1.04 | −87% |
| Doximity, Inc DOCS | $24.74 | $25.91 | +5% |
| Privia Health Group PRVA | $21.07 | $5.26 | −75% |
Compare Kontigo Care AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Kontigo Care AB (KONT) overvalued or undervalued?
What is the fair value of KONT?
What is the quality score of KONT?
What is the revenue of Kontigo Care AB (KONT)?
What is the net profit margin of KONT?
Watch Kontigo Care AB in the live analysis
One click puts Kontigo Care AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.